Interaction of calcium antagonists with cyclic AMP phosphodiesterases and calmodulin.

Abstract The calcium antagonists, nimodipine and nicardipine, competitively inhibited calmodulin-sensitive and calmodulin-insensitive forms of cyclic AMP phosphodiesterase, with IC 50's in the micromolar range. Verapamil showed similar inhibitory potency against calmodulin-insensitive phosphodiesterases, but in marked contrast, it was a very weak inhibitor (30–100 times less potent) against calmodulin-sensitive forms of the enzyme. Verapamil and nimodipine both antagonized the calmodulin stimulation of phosphodiesterase. Through use of hydrophobic fluorescent probes, verapamil, and another calmodulin antagonist, proadifen, were shown to interact directly with calmodulin in a manner that differed from the interaction of calmodulin with trifluoperazine.

[1]  R. Towart,et al.  The cellular mechanism of action of nimodipine (BAY e 9736), a new calcium antagonist [proceedings]. , 1979, British journal of pharmacology.

[2]  M. J. Cormier,et al.  Purification of plant calmodulin by fluphenazine-Sepharose affinity chromatography. , 1979, Biochemical and biophysical research communications.

[3]  D. Burk,et al.  The Determination of Enzyme Dissociation Constants , 1934 .

[4]  E. Antman,et al.  Calcium channel blocking agents in the treatment of cardiovascular disorders. Part II: Hemodynamic effects and clinical applications. , 1980, Annals of internal medicine.

[5]  A. Fleckenstein.  Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle. , 1977, Annual review of pharmacology and toxicology.

[6]  S. Forsén,et al.  Interaction of the antihypertensive drug felodipine with calmodulin , 1981, Nature.

[7]  C. Klee.  Conformational transition accompanying the binding of Ca2+ to the protein activator of 3',5'-cyclic adenosine monophosphate phosphodiesterase. , 1977, Biochemistry.

[8]  H. Hidaka,et al.  Effects of N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide and other calmodulin antagonists (calmodulin interacting agents) on calcium-induced contraction of rabbit aortic strips. , 1981, The Journal of pharmacology and experimental therapeutics.

[9]  E. Hersh,et al.  Cyclic adenosine 3':5'-monophosphate phosphodiesterase. Distinct forms in human lymphocytes and monocytes. , 1976, The Journal of biological chemistry.

[10]  E. Hersh,et al.  Increased cyclic nucleotide phosphodiesterase activity associated with proliferation and cancer in human and murine lymphoid cells. , 1977, Cancer research.

[11]  M. Dixon.  The determination of enzyme inhibitor constants. , 1953, The Biochemical journal.

[12]  T. Tanaka,et al.  Hydrophobic regions function in calmodulin-enzyme(s) interactions. , 1980, The Journal of biological chemistry.

[13]  D. Helfman,et al.  Differential regulation of calcium-dependent and calcium-independent cyclic nucleotide phosphodiesterases from heart by palmitoylcarnitine and palmitoyl coenzyme A. , 1982, Biochimica et biophysica acta.

[14]  P. Cohen,et al.  Stimulation of enzyme activities by fragments of calmodulin , 1981, FEBS letters.

[15]  R. V. Van Inwegen,et al.  Dihydro- and tetrahydroisoquinolines as inhibitors of cyclic nucleotide phosphodiesterases from dog heart. Structure-activity relationships. , 1979, Biochemical pharmacology.

[16]  R. Zelis.  Calcium entry blockers in cardiologic therapy. , 1981, Hospital practice.

[17]  P. Epstein,et al.  Purification and characterization of high-affinity cyclic adenosine monophosphate phosphodiesterase from dog kidney. , 1979, Biochemistry.

[18]  M. Conti,et al.  REGULATION OF MYOSIN LIGHT CHAIN KINASE BY REVERSIBLE PHOSPHORYLATION AND CALCIUM‐CALMODULIN , 1980, Annals of the New York Academy of Sciences.

[19]  M. Samir Amer,et al.  Cyclic nucleotide phosphodiesterases: properties, activators, inhibitors, structure--activity relationships, and possible role in drug development. , 1975, Journal of pharmaceutical sciences.

[20]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[21]  D. Storm,et al.  Calcium-induced exposure of a hydrophobic surface on calmodulin. , 1980, Biochemistry.

[22]  S. Forsén,et al.  A 113Cd NMR study of calmodulin and its interaction with calcium, magnesium and trifluoperazine , 1980, FEBS letters.

[23]  J. N. Wells,et al.  Selective inhibition of cyclic nucleotide phosphodiesterases by analogues of 1-methyl-3-isobutylxanthine. , 1977, Biochemistry.

[24]  M. Terai,et al.  Inhibition of cyclic AMP phosphodiesterase by 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-[2-(N-benzyl-N-methylamino)] ethyl ester 5-methyl ester hydrochloride (YC-93), a potent vasodilator. , 1978, Biochemical pharmacology.